MPT — Medical Properties Trust, Inc. stock price, charts and financials
QT33Medical Properties Trust, Inc.Medical Properties Trust, Inc. (NYSE: MPT) is a Real Estate company in the REIT - Healthcare Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | - | EPS (ttm) | -0.05 | Insider Own | 2.85% | Shs Outstand | 598.10M | Perf Week | -6.59% |
| Market Cap | 2.03B | Forward P/E | 35.62 | EPS next Y | 0.10 | Insider Trans | 0.01% | Shs Float | 490.65M | Perf Month | -18.27% |
| Enterprise Value | 11.34B | PEG | - | EPS next Q | 0.00 | Inst Own | - | Short Float | 30.59% | Perf Quarter | -24.94% |
| Income | -31.00M | P/S | 2.00 | EPS this Y | 200.90% | Inst Trans | - | Short Ratio | 22.36 | Perf Half Y | -27.81% |
| Sales | 1.02B | P/B | 0.45 | EPS next Y | 89.18% | ROA | -0.20% | Short Interest | 150.08M | Perf YTD | -32.00% |
| Book/sh | 7.52 | P/C | 5.12 | EPS next 5Y | - | ROE | -0.66% | 52W High | 6.47 -47.45% | Perf Year | -31.45% |
| Cash/sh | 0.66 | P/FCF | 9.60 | EPS past 3/5Y | - | ROIC | 3.75% | 52W Low | 3.36 1.19% | Perf 3Y | -47.04% |
| Dividend Est. | 0.36 (10.59%) | EV/EBITDA | 10.79 | Sales past 3/5Y | -14.28% -4.89% | Gross Margin | 82.48% | Volatility | 4.40% 3.20% | Perf 5Y | -83.86% |
| Dividend TTM | 0.36 (10.59%) | EV/Sales | 11.13 | EPS Y/Y TTM | 98.76% | Oper. Margin | 56.61% | ATR (14) | 0.15 | Perf 10Y | -77.35% |
| Dividend Ex-Date | Sep 10, 2026 | Quick Ratio | 0.31 | Sales Y/Y TTM | 2.31% | Profit Margin | -2.96% | RSI (14) | 28.61 | Recom | 2.75 |
| Dividend Gr. 3/5Y | -34.23% -21.11% | Current Ratio | 0.31 | EPS Q/Q | 93.75% | SMA20 | -12.11% | Beta | 1.49 | Target Price | 3.80 |
| Payout | -683.51% | Debt/Eq | 2.13 | Sales Q/Q | 7.92% | SMA50 | -20.23% | Rel Volume | 2.64 | Prev Close | 3.60 |
| Employees | 121 | LT Debt/Eq | 1.99 | Earnings | Oct 29 | SMA200 | -30.29% | Avg Volume | 7.88M | Price | 3.40 |
| IPO Date | Jul 07, 2005 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -241.48% 4.86% | Net Debt/EBITDA | 8.85 | Volume | 20,795,200 | Change | -5.56% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-01-26 | Reiterated | Wells Fargo | Underweight | $5.00 → $3.80 |
| Feb-03-26 | Initiated | Maxim | Buy | $8.00 |
| Nov-25-25 | Reiterated | Wells Fargo | Underweight | $7.50 → $5.00 |
| Mar-12-25 | Upgrade | Exane BNP Paribas | Neutral → Outperform | |
| Mar-11-25 | Reiterated | BNP Paribas | $4.00 → $9.00 | |
| Sep-13-24 | Upgrade | Colliers Securities | Neutral → Buy | $6.50 |
| Sep-13-24 | Reiterated | Truist Securities | Hold | $8.00 → $6.00 |
| Sep-12-24 | Reiterated | Mizuho Securities | Neutral | $7.00 |
| Aug-02-24 | Reiterated | Wells Fargo | Underweight | $7.50 |
| Aug-02-24 | Reiterated | Truist Financial | Hold | $5.00 → $8.00 |
Medical Properties Trust, Inc. functions as a self-managed real estate investment trust (REIT). The company specializes in the financing, acquisition, and construction of healthcare properties, all structured under net-lease agreements. Its extensive property holdings encompass a diverse array of medical establishments, such as rehabilitation centers, extended-stay acute care hospitals, outpatient surgical facilities, hospitals catering to women and children, community and regional general hospitals, medical office complexes, and various other specialized care sites. The trust was established in 2003 by its co-founders, Edward K. Aldag Jr., R. Steven Hamner, Emmett E. McLean, and William Gilliard McKenzie, with its principal offices situated in Birmingham, Alabama.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,019 | 972 | 996 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 179 | 36 | 27 | — | — | — | — | — | — | |
| Gross Profit | 841 | 936 | 968 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 130 | 130 | 134 | — | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | — | — | — | — | — | — | |
| Other Operating Expense | 134 | 266 | 447 | — | — | — | — | — | — | |
| Operating Income | 577 | 540 | 387 | — | — | — | — | — | — | |
| Interest Expense | 646 | 510 | 422 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 36 | -267 | -2,329 | — | — | — | — | — | — | |
| Net Income Before Taxes | -33 | -237 | -2,364 | — | — | — | — | — | — | |
| Income Taxes | -3 | 39 | 44 | — | — | — | — | — | — | |
| Consolidated Net Income | -31 | -277 | -2,410 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | -28 | -276 | -2,408 | — | — | — | — | — | — | |
| Net Income | -31 | -277 | -2,410 | — | — | — | — | — | — | |
| EPS (Recurring) | -0.05 | -0.46 | -4.02 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | -0.05 | -0.46 | -4.02 | — | — | — | — | — | — | |
| EPS (Diluted) | -0.05 | -0.46 | -4.02 | — | — | — | — | — | — | |
| EBITDA | 1,051 | 546 | -1,488 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 2.00 | 3.09 | 2.38 | — | — | — | — | — | — | |
| Gross Margin | 82.53 | 96.30 | 97.19 | — | — | — | — | — | — | |
| Operating Margin | 56.62 | 55.56 | 38.86 | — | — | — | — | — | — | |
| Net Margin | -3.04 | -28.50 | -241.97 | — | — | — | — | — | — | |
| Shares Outstanding | 598 | 601 | 600 | — | — | — | — | — | — | |
| Market Capitalization | 2,033 | 3,005 | 2,370 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Hanna James Kevin | Senior VP, Controller & CAO | Aug 20 '26 | Buy | 4.15 | 2,300 | 9,545 | 542,504 | Aug 20 |
| Hooper Rosa Handley | SVP of Operations | Dec 15 '25 | Sale | 5.00 | 2,000 | 10,000 | 395,182 | Dec 16 |
| Stewart Michael G | Director | Nov 19 '25 | Sale | 5.02 | 59,000 | 296,180 | 157,100 | Nov 21 |
| Stewart Michael G | Director | May 05 '25 | Sale | 5.20 | 29,000 | 150,800 | 216,100 | May 05 |
| Hanna James Kevin | Senior VP, Controller & CAO | Mar 05 '25 | Buy | 5.75 | 7,411 | 42,613 | 372,338 | Mar 06 |
| Hanna James Kevin | Senior VP, Controller & CAO | Dec 26 '24 | Sale | 3.72 | 11,641 | 43,305 | 366,913 | Dec 26 |
| Hooper Rosa Handley | SVP of Operations | Dec 23 '24 | Sale | 3.67 | 3,000 | 11,010 | 356,600 | Dec 26 |
| Stewart Michael G | Director | Oct 09 '24 | Sale | 5.46 | 32,780 | 178,979 | 221,245 | Oct 09 |
| Pitman Elizabeth N | Director | Sep 18 '24 | Buy | 6.01 | 8,087 | 48,603 | 76,740 | Sep 19 |
| THOMPSON C REYNOLDS III | Director | Aug 27 '24 | Sale | 4.38 | 20,530 | 89,921 | 54,637 | Aug 27 |
| Pitman Elizabeth N | Director | Aug 15 '24 | Sale | 4.98 | 10,025 | 49,925 | 68,653 | Aug 15 |
| HAMNER R STEVEN | Executive Vice President & CFO | Apr 07 '22 | Sale | 21.04 | 285,000 | 5,996,400 | 1,961,214 | Apr 08 |
| Aldag Edward K JR | Chairman, President & CEO | Mar 30 '22 | Sale | 21.33 | 615,000 | 13,117,950 | 3,497,206 | Apr 01 |
| Stewart Michael G | director: | Mar 10 '22 | Sale | 20.26 | 6,000 | 121,560 | 214,436 | Mar 10 |
| Stewart Michael G | Director | Aug 02 '21 | Sale | 20.88 | 4,800 | 100,224 | 214,884 | Aug 03 |